Innogene이노진
344860 · KOSDAQ · ₩344860 · 이노진
₩1,446 ₩0 (0.00%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Gross margin | 52.5% | 75.7% | 74.2% | 72.6% | 74.3% |
| Operating margin | −5.2% | 0.1% | 7.0% | 12.1% | 16.3% |
| Net margin | −1.4% | 3.5% | 10.6% | 13.8% | 14.7% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue growth | +45.3% | −8.2% | −11.4% | +10.5% | — |
| Operating income growth | −14,039.2% | −99.3% | −48.6% | −17.6% | — |
| Net income growth | −159.5% | −69.5% | −32.3% | +4.2% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Return on equity | −1.3% | 1.9% | 5.8% | 12.3% | 19.9% |
| Return on assets | −1.2% | 1.8% | 5.4% | 11.1% | 16.8% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Liabilities to equity | 10.4% | 6.7% | 5.6% | 7.3% | 17.9% |
| Net debt to equity | −14.4% | −7.6% | −5.1% | −5.2% | −14.7% |
| Current ratio | 905.5% | 1,417.5% | 1,716.2% | 1,352.5% | 528.9% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Innogene / 이노진 / 344860 / KRX:344860
Source: KRX statistical information